Anthraflavicacid

Anthraflavicacid

SCHEMBL124974

O=C1c2ccc(O)cc2C(=O)c2ccc(O)cc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 10/20 1.00
ESR1 P03372 9/20 1.00
MAOA P21397 1/20 1.00
UGT1A1 P22309 1/20 1.00
MAOB P27338 1/20 1.00
TTR P02766 1/20 0.67
BCL2 P10415 3/20 0.58
MCL1 Q07820 3/20 0.58
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
MEN1 O00255 1/20 0.52
NPC1 O15118 1/20 0.52
ALDH1A1 P00352 1/20 0.52
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
RAB9A P51151 1/20 0.52
KMT2A Q03164 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2772476 1.00 ESR2 (1.00) ESR2ESR1MAOAUGT1A1MAOB
Anthraflavicacid SCHEMBL31105422 1.00 ESR2 (1.00) ESR2ESR1MAOAUGT1A1MAOB
Anthraflavicacid SCHEMBL29985684 1.00 ESR2 (1.00) ESR2ESR1MAOAUGT1A1MAOB
Anthraflavicacid SCHEMBL28758924 0.97 ESR2 (0.95) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL25270871 0.95 ESR2 (0.90) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL29486239 0.94 ESR2 (0.90) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL539276 0.94 ESR2 (0.90) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL15676175 0.94 ESR2 (0.90) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL30410371 0.94 ESR2 (0.90) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL18130042 0.93 ESR2 (0.86) ESR2ESR1MAOAUGT1A1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1393 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122051299-A Method for recovering capacity of water system organic flow battery 中国科学院大连化学物理研究所 2026-05-15 CN claimed
CN-122037164-A Polyaryletherketone sequence copolymer, preparation method thereof and application thereof in 3D printing 吉林大学 2026-05-15 CN claimed
CN-119764506-A Negative electrode electrolyte of zinc-iron flow battery and zinc-iron flow battery 中国石油大学(北京) 2025-04-04 CN claimed
US-20250059125-A1 METHOD OF PRODUCING ANTHRAQUINONE-BASED SUBSTANCE MITSUBISHI HEAVY INDUSTRIES, LTD. (JP) 2025-02-20 US claimed
WO-2025034696-A2 LOW CROSSOVER ION EXCHANGE MEMBRANES FOR REDOX FLOW BATTERIES UNIVERSITY OF SOUTH CAROLINA (US) 2025-02-13 WO claimed
CN-118412509-B Acid-base amphoteric iron-sulfur hybrid flow battery and preparation method thereof 安徽恒焺储能科技有限公司 2025-02-07 CN claimed
US-20240429494-A1 PLASMONIC PHOTOELECTRODES FOR PHOTOELECTROCHEMICAL REDOX FLOW BATTERIES DEPARTMENT OF ENERGY 2024-12-26 US claimed
CN-118994907-A Light-weight high-strength flexible polyarylene sulfide composite material and preparation and application thereof 新凝合科技(成都)有限公司 2024-11-22 CN claimed
CN-118813983-A Method for separating cations from acidic vanadium liquid 攀钢集团西昌钒制品科技有限公司 2024-10-22 CN claimed
CN-118825298-A Metal catalyst electrode for flow battery and preparation method thereof, polysulfide-based flow battery and preparation method thereof 深圳市中和储能科技有限公司 2024-10-22 CN claimed
US-4619975-A HEAT RESISTANCE, CHEMICAL RESISTANCE UNION CARBIDE CORPORATION (US) 1986-10-28 US claimed
US-H72-H Organic substitutes for charcoal in black powder THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1986-06-03 US claimed
EP-0170067-A2 Blends of a poly(aryl ether ketone) and a polyarylate AMOCO CORPORATION (US) 1986-02-05 EP claimed
US-4395307-A READILY BROKEN UP INTO FIBRILS; USED IN PAPERS CELANESE CORPORATION (US) 1983-07-26 US claimed
EP-0055989-A2 Liquid crystal with an incorporated pleochroic anthraquinone dyestuff, and process for the preparation of the dyestuff SIEMENS AKTIENGESELLSCHAFT (DE) 1982-07-14 EP claimed
EP-0034832-A1 Liquid crystal with an incorporated pleochroic anthraquinone dyestuff and its use SIEMENS AKTIENGESELLSCHAFT (DE) 1981-09-02 EP claimed
US-4217307-A Process for the preparation of 2,2'-dichloro-hydrazobenzene HOECHST AKTIENGESELLSCHAFT (DE) 1980-08-12 US claimed
EP-0000519-B1 PROCESS FOR THE PREPARATION OF 2,2'-DICHLOROHYDRAZOBENZENE HOECHST AKTIENGESELLSCHAFT (DE) 1980-07-23 EP claimed
EP-0000519-A1 Process for the preparation of 2,2'-dichlorohydrazobenzene HOECHST AKTIENGESELLSCHAFT (DE) 1979-02-07 EP claimed
US-3997705-A Method of coagulating a fluoro-elastomer from an aqueous dispersion thereof DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) 1976-12-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250059125-A1 METHOD OF PRODUCING ANTHRAQUINONE-BASED SUBSTANCE RECQL, FANCD2, RAD51 ESR2 3419/4885ESR1 3055/4885MAOA 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.